Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GB Sciences Inc GBLX

Healthcare
GB Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company. It creates patented, disease-targeted formulations of cannabis and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. (GBSGB). The primary focus for the development of its lead program has been in evaluating suitable... see more

Recent & Breaking News (GREY:GBLX)

GB Sciences (GBLX): A Grow Business with a Moonshot in Biopharma -- CFN Media

Marketwired January 6, 2017

GB Sciences Announces Opening of Las Vegas, Nevada, Indoor Cannabis Grow, Moving GB Sciences into a Revenue Generating Stage

PR Newswire January 4, 2017

GB Sciences, Inc. Engages CFN Media to Cultivate Long Term Investor Audience

Marketwired December 15, 2016

Cannabis Industry Leaders Vying for Land & Asset Acquisitions for Grow Operations

PR Newswire Europe Non Regulatory December 15, 2016

GB Sciences Licenses Patent To Develop New Cannabis-Based Therapies For The Treatment Of Heart Disease

PR Newswire December 13, 2016

Cannabis Stocks Stay Ahead In Exploding Legal Marijuana Market

PR Newswire November 29, 2016

Legal Cannabis Industry Anticipates Growth

PR Newswire November 16, 2016

Businesses Post Legalization of Cannabis

PR Newswire November 14, 2016

The Cannabis Industry Hopeful After Elections

PR Newswire November 11, 2016

Cannabis Legalization at the Forefront this Week

PR Newswire November 9, 2016

More States Vote on Cannabis Legalization

PR Newswire November 7, 2016

Cannabis Companies Trending on Recent News

PR Newswire November 3, 2016

Marijuana Stocks Gaining Major Momentum in U.S. Ahead of Next Week's Elections

PR Newswire November 2, 2016

The Legal Cannabis Market Making Noise

PR Newswire November 1, 2016

Growblox Sciences Announces Patent Application for Treatments of Parkinson's Disease, Alzheimer's Disease, Huntington's Disease and Dementia

PR Newswire October 12, 2016

Letter from CEO of Growblox Sciences Regarding Annual Meeting of Shareholders

PR Newswire October 11, 2016

Growblox Sciences, Inc. Acquires Two Additional Medical Cannabis Cultivation And Production Establishment Licenses In The State Of Nevada

PR Newswire October 4, 2016

Growblox Sciences, Inc. Announces The Opening Of Its First Medical Marijuana Dispensary: "Showgrow" In Las Vegas, Nevada

PR Newswire June 28, 2016

GrowBLOX Sciences, Inc. Announces Exclusive Rights To Kyle Kushman's Cannabis Brands, Strains And Genetics In The State Of Nevada

PR Newswire June 7, 2016